Evidence mapPaperPMID 42010206Full record

ReviewStem cell reviews and reports2026

The Potentials of Stem Cell-Derived Exosomal MicroRNAs in Ferroptosis Modulation: Molecular Insights into Hepatoprotection, Neuroprotection, Cardioprotection, Renoprotection and Pulmonoprotection.

Qamar Abuhassan, Kamel A Saleh, Waleed K Abdulsahib, H Malathi, Priya Priyadarshini Nayak, S Jayashree, Vimal Arora, Ashish Singh Chauhan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qamar AbuhassanDepartment of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Jordan, Amman, 11942, Jordan.
Kamel A SalehFaculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
Waleed K AbdulsahibDepartment of Pharmacology and Toxicology, College of Pharmacy, Al Farahidi University, Baghdad, Iraq. waleedk.abdulsahib@uoalfarahidi.edu.iq.ORCID http://orcid.org/0000-0002-8851-5783
H MalathiDepartment of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
Priya Priyadarshini NayakDepartment of Medical Oncology, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, 751003, India.
S JayashreeDepartment of Biotechnology, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
Vimal AroraUniversity institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India.
Ashish Singh ChauhanUttaranchal Institute of Pharmaceutical Sciences, Division of research and innovation, Uttaranchal University, Dehradun, Uttarakhand, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis is an iron-dependent, regulated form of cell death characterized by lipid peroxidation and disrupted redox homeostasis. This process plays a role in the development of various organ injuries. Stem cell-derived exosomes carrying microRNAs (miRNAs) have recently emerged as a promising therapeutic approach for modulating ferroptosis and providing organ protection. This review summarizes the core molecular mechanisms of ferroptosis, including iron metabolism, lipid peroxidation, the glutathione/GPX4 axis, and regulatory networks involving non-coding RNAs. The biological hallmarks of stem cells, particularly mesenchymal stem cells (MSCs), neural stem cells (NSCs), and induced pluripotent stem cell derivatives (iPSCs), as well as the biogenesis and cargo sorting of exosomal miRNAs, are outlined. Evidence comprehensively shows that stem cell-derived exosomal miRNAs can influence ferroptosis. They provide protective effects in the lungs, liver, nervous system, kidneys, and heart. The review highlights how various exosomal miRNAs target ferroptotic regulators such as SLC7A11, GPX4, and ACSL4, as well as upstream signaling pathways. By tackling the current translational barriers, such as improving exosome engineering, increasing miRNA encapsulation efficiency, ensuring organ-specific delivery, enhancing biosafety, and conducting thorough in vivo validation, stem cell-derived exosomal miRNAs could become a clinically useful and reliable method for precise ferroptosis modulation and multi-organ protection.

Indexed as

ExosomesFerroptosisMicroRNAsNeuroprotectionStem CellsAnimalsHumansLiverMicroRNAsCardiovascular DiseaseEpigenetic RegulationExosomeNeurodegenerative DiseaseNon-coding RNAProgrammed Cell Death

Identifiers

PMID42010206

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.